About Orbit Biomedical
Orbit Biomedical is a company based in Ambler (United States) founded in 2018 was acquired by Gyroscope in April 2019. Orbit Biomedical has raised $12 million across 1 funding round from investors including Syncona and Novartis. Orbit Biomedical operates in a competitive market with competitors including Alcon, Sight Sciences, Keranova, Iantrek and Migos Medical, among others.
- Headquarter Ambler, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Orbit Biomedical
Unlock access to complete
Unlock access to complete
Board Team
8 people
Operations Team
5 people
Software Development Team
3 people
Human Resources and Administration
3 people
Leadership Team
2 people
Senior Team
2 people
Finance and Accounting
2 people
Product Management Team
2 people
Unlock access to complete
Funding Insights of Orbit Biomedical
Orbit Biomedical has successfully raised a total of $12M through 1 strategic funding round. The most recent funding activity was a Series A round of $12 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Orbit Biomedical
Orbit Biomedical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Syncona and Novartis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Locked | Locked | Locked | |
|
Gene therapies for eye diseases, focusing on AMD, are developed.
|
Locked | Locked | Locked |
Investor details for Orbit Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orbit Biomedical
Investment portfolio details for Orbit Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orbit Biomedical
Detailed financials for Orbit Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orbit Biomedical Comparisons
Peer comparison for Orbit Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orbit Biomedical
Orbit Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alcon, Sight Sciences, Keranova, Iantrek and Migos Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a wide range of eye care products
|
|
| Locked | Locked | Locked |
Surgical systems for ophthalmological disease treatment are developed.
|
|
| Locked | Locked | Locked |
Surgical equipment for anterior chamber ophthalmic surgery is developed.
|
|
| Locked | Locked | Locked |
Developer of a minimally invasive eye surgery technology
|
|
| Locked | Locked | Locked |
Minimally invasive ophthalmology devices for glaucoma are developed.
|
Detailed competitors of Orbit Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orbit Biomedical
Complete news archive for Orbit Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orbit Biomedical
Orbit Biomedical was founded in 2018.
Orbit Biomedical is headquartered in Ambler, United States. It is registered at Ambler, Pennsylvania, United States.
Orbit Biomedical is a funded company, having raised a total of $12M across 1 funding round to date.
Orbit Biomedical was founded in 2018 and is headquartered in Ambler, United States. Operations center on the biomedical sector, where a specialized medical device is developed for ophthalmic surgery. This device enables delivery of one-time therapies to the subretinal space, targeting blinding eye diseases. Access to the subretinal space is achieved without vitrectomy or retinal piercing, supporting minimally invasive procedures in eye care.
Orbit Biomedical's top competitors include Alcon, Sight Sciences and Iantrek.